Clinical Research Directory
Browse clinical research sites, groups, and studies.
Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery
Sponsor: Cairo University
Summary
Epinephrine is a well-known vasoactive agent in medical practice. However, its use is obstetric population is still scanty. Few studies evaluated the use of epinephrine during Cesarean delivery and a recent randomized controlled dose-finding trial reached an acceptable incidence of hypotension (13%) with the use of 0.03 mcg/kg/min as prophylaxis. Being a newly introduced vasoactive agent in obstetric practice, it is essential to be adequately compared with other vasopressors using the optimum dosage and appropriate outcomes. There are no data, till date, comparing epinephrine versus norepinephrine infusion during Cesarean delivery using a composite outcome of hypotension, hypertension, and bradycardia. The aim of this study is to compare epinephrine versus norepinephrine infusion for prophylaxis against post-spinal hypotension during Caesarean delivery
Official title: Epinephrine Versus Norepinephrine Infusion for Prevention of Maternal Hypotension During Caesarean Delivery: a Randomized Clinical Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
212
Start Date
2024-08
Completion Date
2024-12
Last Updated
2024-07-22
Healthy Volunteers
No
Conditions
Interventions
Norepinephrine
patients will receive norepinephrine infusion at rate of 0.05 mcg/Kg/min
Epinephrine
patients will receive epinephrine infusion dose of 0.03 mcg/Kg/min
Locations (1)
Cairo University
Cairo, Egypt